Tylenol maker Kenvue ousts CEO amid board’s strategic review

Tylenol maker Kenvue ousts CEO amid board's strategic review

Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its struggling skin health and beauty unit which includes brands like Neutrogena and Aveeno.

Read More…